跳至主要内容
临床试验/NCT06253559
NCT06253559已完成不适用

Clinical and Pathological Characteristics of Women With Ovarian Cancers, A National, Retrospective Cross-Sectional Study in Syria During the War

Tishreen University1 个研究点 分布在 1 个国家目标入组 531 人开始时间: 2017年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
531
试验地点
1
主要终点
age

研究概览

简要总结

the goal of this observational study is to describe ovarian cancer epidemiology and characteristics in Syrian women, especially during the war to do more research in the future about the risk factors of ovarian cancer.

详细描述

Ovarian cancer (OC) is the eighth most common cause of death worldwide, and current studies show that the death numbers caused by it will rise dramatically in the coming years. As the epidemiological features of the cancer may vary, studying these different characteristics can help us improve treatment outcomes and add preventive measures. In addition, giving special attention to these features in developing countries, or countries undergoing crisis, will help us understand the associated risk factors in these regions.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • female adult (age ≥18 years)
  • primary ovarian malignancy

排除标准

  • less than 18 years old
  • women who have benign tumors or metastatic ovarian cancer.

结局指标

主要结局

age

时间窗: jan 2017 - july 2021

the age of patients at the time of diagnosis

ovarian cancer grade

时间窗: jan 2017 - july 2021

ovarian cancer grades frequency among patients

Treatment

时间窗: jan 2017 - july 2021

detect if the patient underwent surgery or chemotherapy or the both

histological type of ovarian cancer

时间窗: jan 2017 - july 2021

detect the most common type of ovarian cancer

Cancer Antigen-125

时间窗: jan 2017 - july 2021

Cancer Antigen-125 levels, if they are normal or high in ovarian cancer.

symptoms of ovarian cancer

时间窗: jan 2017 - july 2021

detect symptoms of disease at diagnosis time

sideness of ovarian cancer

时间窗: jan 2017 - july 2021

study the frequency of bilateral or unilateral ovarian cancer

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验